0001376474-26-000247.txt : 20260324 0001376474-26-000247.hdr.sgml : 20260324 20260324155508 ACCESSION NUMBER: 0001376474-26-000247 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260324 DATE AS OF CHANGE: 20260324 EFFECTIVENESS DATE: 20260324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Porosome Therapeutics, Inc. CENTRAL INDEX KEY: 0001934919 ORGANIZATION NAME: EIN: 873482047 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-492097 FILM NUMBER: 26785983 BUSINESS ADDRESS: STREET 1: ONE BOSTON PLACE, STE 2631 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 781 956 9799 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE, STE 2631 CITY: BOSTON STATE: MA ZIP: 02108 FORMER COMPANY: FORMER CONFORMED NAME: Viron Therapeutics Holdings, Inc. DATE OF NAME CHANGE: 20220622 D/A 1 primary_doc.xml X0708 D/A LIVE 0001934919 Porosome Therapeutics, Inc. ONE BOSTON PLACE, STE 2631 BOSTON MA MASSACHUSETTS 02108 781 956 9799 DELAWARE Viron Therapeutics Holdings, Inc. Corporation true 2021 Guillermo Marmol One Boston Place Suite 2631 Boston MA MASSACHUSETTS 02108 Executive Officer Biotechnology No Revenues 06b true 0001376474-25-000506 2023-09-08 false true false 50000 Indefinite 3625000 Indefinite false 7 0 0 0 The Chief Executive Officer, Guillermo Marmol, receives no compensation from the proceeds. false Porosome Therapeutics, Inc. /s/ Guillermo Marmol Guillermo Marmol Chief Executive Officer 2026-03-20